Skip to content
  • Home
  • Legal Developments
  • Press Releases
  • Rankings
  • Profiles
  • GC Powerlist
  • Events
  • GC Magazine
  • fivehundred
  • Comparative Guides
  • In-House Lawyer
  • Webinars
  • About

Legal Developments - Law Firm Thought Leadership

Reset

Autonomy over Oversight: Why Independent Cooperative Societies Are Not “State” Under Article 12 and Why Their Elections Fall Outside Writ Jurisdiction

King, Stubb & Kasiva | July 1, 2026

Introduction The intersection of cooperative society governance, constitutional law, and writ jurisdiction has been a subject of enduring judicial discourse in India. A recurring question before courts is whether cooperative societies — particularly those that operate independently of Government control — can be classified as “State” under Article 12 of the Constitution of India, thereby …

Continue reading “Autonomy over Oversight: Why Independent Cooperative Societies Are Not “State” Under Article 12 and Why Their Elections Fall Outside Writ Jurisdiction”

Supreme Court Settles the Limitation Question in Post-Award Proceedings: Section 33 Exception to the Running of Limitation Under Section 34(3) Applies Regardless of Maintainability or Outcome.

King, Stubb & Kasiva | July 1, 2026

I. Introduction What happens if a party files an application under Section 33 of the Arbitration and Conciliation Act, 1996 (“the Act”) seeking correction of an arbitral award, does the limitation period for challenging the award under Section 34 run from the date of the original award, or from the date on which the Section …

Continue reading “Supreme Court Settles the Limitation Question in Post-Award Proceedings: Section 33 Exception to the Running of Limitation Under Section 34(3) Applies Regardless of Maintainability or Outcome.”

Health Canada releases guidance on biosimilar biologic drug submissions

DLA Piper (Canada) LLP | July 1, 2026

Written by:Bentley GaikisNicole Nazareth In May 2026, Health Canada published its Guidance on Information and Submission Requirements for Biosimilar Biologic Drugs. This guidance sets out the regulatory framework under which biosimilar sponsors may seek a Notice of Compliance (NOC) for a biosimilar biologic drug in Canada.

Canada unveils national AI strategy: Key commitments, regulatory gaps, and what’s missing

DLA Piper (Canada) LLP | July 1, 2026

Authors:Ryan BlackMorgan McDonaldMiles SchaffrickSuman Singh On June 4, 2026, the Government of Canada released AI for All: Canada’s National Artificial Intelligence Strategy, a 50-page, multi-billion-dollar plan positioning Canada as a global AI leader across six strategic pillars (protecting Canada/democracy, empowering Canadians, powering prosperity, sovereign AI infrastructure, scaling Canadian AI, and international partnerships) and five priority sectors (health/life …

Continue reading “Canada unveils national AI strategy: Key commitments, regulatory gaps, and what’s missing”

Equal treatment wage rules for federally regulated employers

DLA Piper (Canada) LLP | July 1, 2026

Written by:Duncan Burns-ShillingtonGarrett Ladd (Summer Student) At a glance Effective 20 October 2026, new “Equal Treatment” wage rules under the Canada Labour Code (the Code) will require equal pay for employees regardless of employment status (full-time, part-time, permanent, or temporary). Employers must avoid differences in wage rates based on an employee’s employment status where the …

Continue reading “Equal treatment wage rules for federally regulated employers”

Federally regulated employers face a new era for non-compete clauses under Bill C-31

DLA Piper (Canada) LLP | July 1, 2026

Authors:Struan RobertsonGarrett Ladd (Student) Bill C-31’s proposed amendments to the Canada Labour Code signal a shift in the regulation of workplace restrictive covenants in Canada. If enacted, the legislation would significantly limit the use of non-compete clauses for federally regulated employers and continue a broader national trend favouring employee mobility and labour market competition.

Executive Order No. 407/2026 issues new regulations for Argentina’s employment laws

DLA Piper Argentina | July 1, 2026

Written by:Alberto RubioMaría Florencia Labarile On June 1, 2026, Executive Order No. 407/2026 (Order) was published in Argentina’s Official Gazette, implementing regulations for various provisions of the Employment Contract Law No. 20,744 (LCT), as amended by the Labor Modernization Act No. 27,802, in addition to regulations governing collective bargaining (Law No. 14,250), trade union organizations (Law …

Continue reading “Executive Order No. 407/2026 issues new regulations for Argentina’s employment laws”

Puerto Rico Supreme Court validates non-compete clauses in independent contractor agreements

DLA Piper Puerto Rico | July 1, 2026

Written by:Janine GuzmánLeonardo Nuñez For the first time, the Puerto Rico Supreme Court has upheld the validity of non-compete clauses in contracts with independent contractors, specifically in the healthcare sector, and, in doing so, it has established the framework for their enforcement. In this alert, we outline the Court’s opinion in MCG Therapy Group LLC v. Maestre Rivera and …

Continue reading “Puerto Rico Supreme Court validates non-compete clauses in independent contractor agreements”

Juntos – June 2026 Updates on Antitrust and Competition Enforcement in Latin America

DLA Piper LLP (US) | July 1, 2026

Regional Spanish CNMC hosts annual meeting of Ibero-American Association of Energy Regulatory Authorities and adopts Madrid Declaration. In May 2026, the Spanish Competition Authority (CNMC), which is also the energy regulator in Spain, hosted the annual meeting of the Ibero-American Association of Energy Regulatory Authorities (Asociación Iberoamericana de Entidades Reguladoras de la Energía, or ARIAE). Regulators …

Continue reading “Juntos – June 2026 Updates on Antitrust and Competition Enforcement in Latin America”

Jenec: the limits of automatic de-risking in EU banking law

Elias Neocleous & Co LLC | June 30, 2026

On 11 June 2026, the Court of Justice of the European Union (the “Court”) delivered its judgment in Case C-81/24, Jenec. The case concerned the relationship between the right of access to a payment account with basic features under Directive 2014/92/EU (the “Payment Accounts Directive”) and the AML/CFT obligations imposed on financial institutions under Directive …

Continue reading “Jenec: the limits of automatic de-risking in EU banking law”

Developments

Press Releases

  • LinkedIn
  • Twitter
  • Facebook
  • YouTube
  • Email
© 2026 Legalease Ltd. All rights reserved
Registered company in England & Wales No. 2427356 VAT 321572722
Registered address: 188 Fleet Street, London, EC4A 2AG
  • Data Protection policies
  • |
  • Cookies Policy
  • |
  • FAQs
  • |
  • Contact Us